First patient dosed in an outpatient setting, discharged the same day; multiple patients in the process of screening at ...

The trial will enrol around 53 participants and aims to complete enrolment in 15 to 18 months.

A new study published in the journal of Rheumatology showed that over time, people with systemic lupus erythematosus (SLE) who do not exhibit signs of lupus nephritis (LN) and have ...

Lupus nephritis is a serious complication of lupus — and because it doesn’t always cause symptoms right away, it’s important to find it early. Talk to your lupus doctor about getting screened (tested) ...

Aurinia Pharmaceuticals is running the phase 4 PRESERVE trial in lupus nephritis, which tests the company's drug Lupkynis.

Medical experts illustrate characteristics in the presentation of lupus nephritis. Jorge Larranaga, MD: Lupus nephritis can present in several ways. Lupus may take up to 6 years to be diagnosed. About ...

Rheumatologist Ellen Ginzler, MD, MPH, and nephrologist German Hernandez, MD, FASN, FACP, provide an overview of systemic lupus erythematosus and lupus nephritis. Ellen Ginzler, MD, MPH: SLE, or ...

In lupus nephritis, attainment of complete renal response (CRR)/partial renal response (PRR) and lupus low disease activity state (LLDAS) is associated with best relapse-free survival, with ...

This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Brad Rovin, MD: ...

Objective Belimumab has been proven to be effective for treating refractory lupus nephritis. However, the meaningful renal ...

Lupus nephritis is one of the most serious complications of systemic lupus erythematosus (SLE). It occurs when the immune system mistakenly attacks the kidneys, leading to inflammation and possibly to ...